Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets - Narrative (Details)

v3.21.2
Intangible Assets - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Intangible assets        
Amortization of intangible assets $ 49 $ 36 $ 96 $ 72
Sales and Marketing Expense        
Intangible assets        
Royalty fees included in sales and marketing expense $ 709 $ 436 $ 1,350 $ 929
License agreements        
Intangible assets        
Notice period for termination of license agreements     60 days  
Minimum royalty of agreements     $ 13  
Milestone fee upon receiving a Phase II Small Business Innovation Research     15  
Milestone fee upon FDA approval     2  
Milestone fee upon first commercial use of certain licensed technology     25  
Milestone fee upon first use to manufacture products that utilize certain technology not currently incorporated into AxoGen products     $ 10  
Minimum | License agreements        
Intangible assets        
Amortization period of intangible assets     17 years  
Royalty fees range under the license agreements     1.00%  
Maximum | License agreements        
Intangible assets        
Amortization period of intangible assets     20 years  
Royalty fees range under the license agreements     3.00%  
Royalty stack cap for royalties paid to more than one licensor for sales of the same product     3.75%  
Maximum | Patents        
Intangible assets        
Amortization period of intangible assets     20 years